21 Mar 2024
// PHARMATECH
23 Nov 2023
// PRESS RELEASE
18 May 2023
// PHARMTECH
Latest Content by PharmaCompass
Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #5D97
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #5D97
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
CORPORATE CONTENT #SupplierSpotlight
21 Mar 2024
// PHARMATECH
https://www.pharmtech.com/view/phosgene-at-valsynthese-an-atom-economic-reagent-that-demonstrates-exceptional-versatility
23 Nov 2023
// PRESS RELEASE
https://www.valsynthese.ch/files/Press%20releases/press-release_grignard_def.pdf
18 May 2023
// PHARMTECH
27 Oct 2022
// PRESS RELEASE
https://www.valsynthese.ch/files/Press%20releases/View%20of%20VALSYNTHESE,%20YOUR%20SERVICE%20PREMIUM%20PARTNER%20IN%20CDMO%20FIELD_October%202022.pdf
29 Jul 2022
// PRESS RELEASE
https://www.valsynthese.ch/files/Press%20releases/CKH_June_July_2022_Valsynthese.pdf
https://www.socma.org/max-lauwiner-appointed-head-of-fine-chemicals-unit-at-valsynthese-and-member-of-the-management-team/
Services
API Manufacturing
API & Drug Product Development